Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer

Abstract

Treatment regimen parameter made the largest contribution to OS prognosis in both nomograms, and these nomograms might provide clinicians and patients a simple tool that improves their ability to accurately estimate survival based on individual patient parameters rather than using an averaged predefined treatment regimen.